SCHEMBL19796902

SCHEMBL19796902

C=CC(=O)OCCOc1cc(C2CCC(C)CC2)ccc1-c1ccc(CCO)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.37
FFAR4 Q5NUL3 5/20 0.36
CSF1R P07333 2/20 0.35
FASN P49327 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
MCHR1 Q99705 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
PPARG P37231 2/20 0.32
PPARA Q07869 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ITK Q08881 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804596 0.90 FFAR4 (0.42) THRBFFAR4CSF1RTSHRKDM4E
SCHEMBL19624524 0.87 FFAR4 (0.36) FFAR4CSF1RFASNTSHRALDH1A1
SCHEMBL19624518 0.86 THRB (0.38) THRBFFAR4TSHRPPARGPPARA
SCHEMBL19796897 0.86 THRB (0.38) THRBFFAR4TSHRPPARGPPARA
SCHEMBL19804569 0.84 FFAR4 (0.42) THRBFFAR4TSHRKDM4EPPARG
SCHEMBL19804618 0.83 FFAR4 (0.44) THRBFFAR4CSF1RKDM4EPPARG
SCHEMBL19804802 0.83 FFAR4 (0.40) THRBFFAR4CSF1RTSHRPPARG
SCHEMBL19796448 0.82 FFAR4 (0.43) THRBFFAR4TSHRALDH1A1KDM4E
SCHEMBL19796442 0.81 THRB (0.47) THRBFFAR4TSHRALDH1A1SMN1; SMN2
SCHEMBL19797126 0.81 THRB (0.39) THRBFFAR4PPARGPPARAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 THRB 4323/4885FFAR4 1715/4885CSF1R 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.